{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T15:10:23Z","timestamp":1770822623172,"version":"3.50.1"},"reference-count":15,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[1999,12,1]],"date-time":"1999-12-01T00:00:00Z","timestamp":944006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100007048","name":"Mayo Foundation for Medical Education and Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007048","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007197","name":"U.S. Public Health Service","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007197","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Mayo Clinic Proceedings"],"published-print":{"date-parts":[[1999,12]]},"DOI":"10.4065\/74.12.1191","type":"journal-article","created":{"date-parts":[[2009,1,24]],"date-time":"2009-01-24T01:16:10Z","timestamp":1232759770000},"page":"1191-1197","source":"Crossref","is-referenced-by-count":52,"title":["Echocardiographic Improvement Over Time After Cessation of Use of Fenfluramine and Phentermine"],"prefix":"10.4065","volume":"74","author":[{"given":"Donald D.","family":"Hensrud","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Heidi M.","family":"Connolly","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martha","family":"Grogan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fletcher A.","family":"Miller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kent R.","family":"Bailey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael D.","family":"Jensen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.4065\/74.12.1191_bib1","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1056\/NEJM199708283370901","article-title":"Valvular heart disease associated with ienfluramine-phentcrmmc [published correction appears in N Engl J Med. 1997;337:1783]","volume":"337","author":"Connolly","year":"1997","journal-title":"N Engl J Med"},{"key":"10.4065\/74.12.1191_bib2","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1056\/NEJM199708283370911","article-title":"Further cases of valvular heart disease associated with fenfluramine-phentermine [letter]","volume":"337","author":"Graham","year":"1997","journal-title":"N Engl J Med"},{"key":"10.4065\/74.12.1191_bib3","first-page":"1061","article-title":"Cardiac valvulopathy associated with exposure lo fenfluramine or dexfenfluramine: US Department of Health and Human Services interim public health recommendations, November 1997","volume":"46","year":"1997","journal-title":"MMWR Morb Mortal Wkty Rep"},{"key":"10.4065\/74.12.1191_bib4","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1056\/NEJM199809103391101","article-title":"The prevalence of cardiac valvular insufficiency assessed by transthoracic echocardiography in obese patients treated with appetite-suppressant drugs","volume":"339","author":"Khan","year":"1998","journal-title":"N Engl J Med"},{"key":"10.4065\/74.12.1191_bib5","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1056\/NEJM199809103391102","article-title":"A population-based study of appetite-suppressant drugs and die risk of cardiac-valve regurgitation","volume":"339","author":"Jick","year":"1998","journal-title":"N Engl J Med"},{"key":"10.4065\/74.12.1191_bib6","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1056\/NEJM199809103391103","article-title":"An assessment of heart-valve abnormalities in obese patients taking dexfenfluramine, sustained-release dexfenfluramine, or placebo","volume":"339","author":"Weissman","year":"1998","journal-title":"JV Engl J Med"},{"key":"10.4065\/74.12.1191_bib7","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1002\/j.1550-8528.1999.tb00414.x","article-title":"Serial cchocardiographic and clinical evaluation of valvular regurgitation before, during, and after treatment with fenfluramine or dexfenfluramine and mazindol orphenlermine","volume":"7","author":"Ryan","year":"1999","journal-title":"Obes Res"},{"key":"10.4065\/74.12.1191_bib8","first-page":"271","article-title":"Two-dimensional real-time ultrasonic imaging of the heart and great vessels: technique, image orientation, structure identification, and validation","volume":"53","author":"Tajik","year":"1978","journal-title":"Mayo Clin Proc"},{"key":"10.4065\/74.12.1191_bib9","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/S0025-6196(12)60540-0","article-title":"Doppler echocardiography: theory, instrumentation, technique, and application","volume":"60","author":"Nishimura","year":"1985","journal-title":"Mayo Clin Proc"},{"key":"10.4065\/74.12.1191_bib10","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1016\/S0735-1097(87)80254-1","article-title":"Evaluation of aortic insufficiency by Doppler color flow mapping","volume":"9","author":"Perry","year":"1987","journal-title":"J Am Coll Cordial"},{"key":"10.4065\/74.12.1191_bib11","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1161\/01.CIR.75.1.175","article-title":"Color Doppler assessment of mitral regurgitation with orthogonal planes","volume":"75","author":"Helmcke","year":"1987","journal-title":"Circulation"},{"key":"10.4065\/74.12.1191_bib12","doi-asserted-by":"crossref","first-page":"870","DOI":"10.7326\/0003-4819-129-11_Part_1-199812010-00005","article-title":"Risk for valvular heart disease among users of fenfluramine and dexfenfluramine who underwent echocardiography before use of medication","volume":"129","author":"Wee","year":"1998","journal-title":"Ann Intern Med"},{"key":"10.4065\/74.12.1191_bib13","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1056\/NEJM199809103391112","article-title":"Regression of multivalvular regurgitation after the cessation of fenfluramine and phenlermine treatment [letter]","volume":"339","author":"Cannistra","year":"1998","journal-title":"NEnglJ Med"},{"issue":"suppl 3","key":"10.4065\/74.12.1191_bib15","first-page":"S76","article-title":"Relationship between significant weight loss and cardiac valvulopathy [abstract]","volume":"22","author":"Khan","year":"1998","journal-title":"Int J Obes Relat Metab Disord"},{"key":"10.4065\/74.12.1191_bib16","doi-asserted-by":"crossref","first-page":"1949","DOI":"10.1161\/01.CIR.98.18.1949","volume":"98","author":"Bonow","year":"1998","journal-title":"Circulation"}],"container-title":["Mayo Clinic Proceedings"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025619611641505?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025619611641505?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,4,5]],"date-time":"2021-04-05T09:41:56Z","timestamp":1617615716000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0025619611641505"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1999,12]]},"references-count":15,"journal-issue":{"issue":"12","published-print":{"date-parts":[[1999,12]]}},"alternative-id":["S0025619611641505"],"URL":"https:\/\/doi.org\/10.4065\/74.12.1191","relation":{},"ISSN":["0025-6196"],"issn-type":[{"value":"0025-6196","type":"print"}],"subject":[],"published":{"date-parts":[[1999,12]]}}}